Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Aug 28;7(8):e015748.
doi: 10.1136/bmjopen-2016-015748.

Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis

Jean Joel Bigna  1   2 , Marie A Amougou  3   4 , Serra Lem Asangbeh  5 , Angeladine Malaha Kenne  1 , Jobert Richie Nansseu  6
Affiliations
Meta-Analysis

Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis

Jean Joel Bigna et al. BMJ Open. .

Abstract

Objective: Better knowledge of hepatitis C virus (HCV) seroprevalence at the national level can help to implement pertinent strategies to address the HCV-related burden. The aim of this paper was to estimate the seroprevalence of HCV infection in Cameroon.

Design: Systematic review and meta-analysis.

Participants: People residing in Cameroon.

Data sources: Electronic databases including PubMed/MEDLINE, AJOL, WHO-Afro Library, Africa Index Medicus, National Institute of Statistics and National AIDS Control Committee, Cameroon from 1 January 2000 to 15 December 2016 were searched. English and French languages papers were considered. Two independent investigators selected studies. The methodological quality of the studies was assessed using the Newcastle-Ottawa scale.

Results: 31 studies including 36 407 individuals were finally considered. There was no national representative study. The overall pooled prevalence was 6.5% (95% CI 4.5% to 8.8%; I²=98.3%). A sensitivity analysis of individuals at low risk of HCV infection showed a pooled prevalence of 3.6% (95% CI 2.3% to 5.2%, I²=97.7%, 18 studies) among 22 860 individuals (general population, blood donors and pregnant women), which was higher than for a high-risk population (healthcare workers and people with other identified comorbidities), 12.2% (95% CI 4.9% to 22.2%; I²=98.3%, 13 studies); p=0.018. The prevalence was higher in the East region, in rural settings, and when using an enzyme immunoassay technique for detecting HCV antibodies. Sex, sites, study period, sample size, timing of data collection and methodological quality of studies were not sources of heterogeneity.

Limitation: One-third of studies (29.0%) had a low risk bias in their methodology and most were facility-based (87.1%).

Conclusion: The seroprevalence of HCV infection in Cameroon indicates the need for comprehensive and effective strategies to interrupt HCV transmission in the Cameroonian population. Specific attention is needed for the East region of the country, rural settings and high-risk populations. A national representative study is needed to provide better estimates.

Keywords: cameroon; epidemiology; hepatitis c; prevalence; systematic review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Process of identification and selection of studies for inclusion in the review.
Figure 2
Figure 2
Forest plot of the prevalence of hepatitis C virus infection in all subpopulations in Cameroon.
Figure 3
Figure 3
Forest plot of the prevalence of hepatitis C virus infection in subpopulations by infection risk status in Cameroon.
Figure 4
Figure 4
Forest plot of the prevalence of hepatitis C virus infection in subpopulations at low risk in Cameroon.
See this image and copyright information in PMC

References

    1. World Health Organization. Hepatitis C: Key facts. 2016. http://www.who.int/mediacentre/factsheets/fs164/en/.
    1. Lozano R, Naghavi M, Foreman K, et al. . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–128. 10.1016/S0140-6736(12)61728-0 - DOI - PMC - PubMed
    1. World Health Organization. Global Health Sector Strategy on Viral Hepatitis, 2016-2021 2016. http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pd....
    1. Rao VB, Johari N, du Cros P, et al. . Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 2015;15:819–24. 10.1016/S1473-3099(15)00006-7 - DOI - PubMed
    1. Riou J, Aït Ahmed M, Blake A, et al. . Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. J Viral Hepat 2016;23:244–55. 10.1111/jvh.12481 - DOI - PubMed

LinkOut - more resources